Obesity | PDF
2026: A 5-year financial impact of employer coverage of semaglutide for patients with obesity
Diabetes | PDF
2025: Adherence to once-weekly injectable semaglutide and associated risk factors in patients with type 2 diabetes in the United States
Diabetes | PDF
2025: Oral semaglutide adherence and associated risk factors in patients with type 2 diabetes in the United States
Cardiovascular Disease | PDF
2026: Systemic Inflammation and Its Association with Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction
Cardiovascular Disease | PDF
NEXUS 2025: Economic Burden Associated with Systemic Inflammation in Patients with Established Atherosclerotic Cardiovascular Disease and Stage 3-4 Chronic Kidney Disease
Liver Health | PDF
NEXUS 2025: Healthcare Resource Utilization and Costs in Patients with Metabolic Dysfunction-Associated Steatohepatitis: A Comparison Between Patients with Probable MASH, Without MASH, and Diagnosed MASH
Liver Health | PDF
NEXUS 2025: Real-World Healthcare Resource Utilization and Costs Among 100% Fee-For-Service Medicare Beneficiaries With Metabolic Dysfunction-Associated Steatohepatitis
Hemophilia | PDF
2025: Resource utilization and economic burden amongst a cohort of patients with hemophilia with inhibitors in the United States
Hemophilia | PDF
NEXUS 2025: Assessing Costs and Healthcare Resource Utilization in Non-Inhibitor Hemophilia A and B Patients in the United States
Hemoglobinopathies | PDF
NEXUS 2025: Association of Acute Pain and Fatigue on Health Care Resource Utilization and Costs in Patients With Sickle Cell Disease in the United States
Novo Nordisk Medical is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products. It provides evidence-based information on a variety of topics important to patient care. All information is for educational purposes only and is not intended to promote any products.
Find product information
Explore our portfolio of products, including prescribing information, safety data sheets, and storage and stability information.
Continuing education
Learn about accredited disease education opportunities supported by Novo Nordisk and provided by third-party organizations.